Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer

Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer

In the article entitled “Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer” (1), the affiliation of Fengrui Xu should be corrected as follows: ¹Department of Breast Oncology, Academy of Military Medical Sciences, Beijing 100089, China; ²Department of Breast Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China

We regret the errors.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Xu F, Jiang Z. Prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer. Ann Transl Med 2020;8:138. [Crossref] [PubMed]